EUVIMEDEUVIMED entdecken
Crossref

Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?

Serdar Madendere iD, Mert Kılıç, Bengi Gürses, Metin Vural, Ayşe Armutlu, İbrahim Kulaç, Kayhan Tarım, Barış Esen, İbrahim Can Aykanat, Mert Veznikli, Abdullah Erdem Canda, Derya Balbay und 3 weitere

International Journal of Urology · 2024

DOI: 10.1111/iju.15553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2024. Verfasst von Serdar Madendere und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, VKV American Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Nomograms, Lymphatic Metastasis, Prostatectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to modify the Briganti 2019 nomogram and to test whether it is valid for patients who were diagnosed with prostate cancer through in‐bore prostate biopsies.

Methods

Data for 204 patients with positive multiparametric prostate MRI and prostate cancer identified either by mpMRI‐cognitive/software fusion or in‐bore biopsy and who underwent robot‐assisted radical prostatectomy and extended pelvic lymph node dissection between 2012 and 2023 were retrospectively analyzed. The Briganti 2019 nomogram was applied to the mpMRI‐cognitive/software fusion biopsy group (142 patients) in the original form, and then, two modifications were tested for the targeted component. Original and modified scores were compared. These modifications were adapted for the in‐bore biopsy group (62 patients). The final histopathologic stage was regarded as the gold standard.

Results

Nodal metastases were identified in 18/142 (12.6%) of mpMRI‐cognitive/software fusion biopsy patients and 8/62 (12.9%) of the in‐bore biopsy patients. In the mpMRI‐cognitive/software fusion biopsy group, tumor size/core size (%) of targeted biopsy cores and positive core percentage on systematic biopsy were significant parameters for lymph node metastasis based on univariate logistic regression analyses ( p < 0.05). With the modifications of these parameters for the in‐bore biopsy group, V1 modification of the Briganti 2019 nomogram provided 100% sensitivity and 31.5% specificity (AUC:0.627), while V2 modification provided 75% sensitivity and 46.3% specificity (AUC:0.645).

Conclusions

Briganti 2019 nomogram may be modified by utilizing tumor size/core size (%) for targeted biopsy cores instead of positive core percentage on systematic biopsy or by not taking both parameters into consideration to detect node metastasis risk of patients diagnosed with in‐bore biopsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsNomogramsLymphatic MetastasisProstatectomyImage-Guided BiopsyHumansMaleAgedRetrospective StudiesMiddle AgedLymph Node ExcisionMultiparametric Magnetic Resonance ImagingProstateLymph NodesRisk AssessmentRobotic Surgical Procedures

Stichwörter der Autor:innen

lymph node metastasisnomogramsprostate cancertargeted biopsy

Autor:innen und Institutionen

  • Department of Urology, VKV American Hospital, Istanbul, Turkey.
  • Department of Radiology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Radiology, VKV American Hospital, Istanbul, Turkey.
  • Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Urology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Biostatistics, Koç University School of Medicine, Istanbul, Turkey.

ORCID-Profile: Serdar Madendere

Zitieren

APA

Madendere, S., Kılıç, M., Gürses, B., Vural, M., Armutlu, A., Kulaç, İ., Tarım, K., Esen, B., Aykanat, İ. C., Veznikli, M., Canda, A. E., Balbay, D., Baydar, D. E., Kordan, Y., & Esen, T. (2024). Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?. International Journal of Urology. https://doi.org/10.1111/iju.15553

Vancouver

Madendere S, Kılıç M, Gürses B, Vural M, Armutlu A, Kulaç İ, et al. Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?. International Journal of Urology. 2024. doi:10.1111/iju.15553

BibTeX
@article{Madendere2024,
  author = {Madendere, Serdar and Kılıç, Mert and Gürses, Bengi and Vural, Metin and Armutlu, Ayşe and Kulaç, İbrahim and Tarım, Kayhan and Esen, Barış and Aykanat, İbrahim Can and Veznikli, Mert and Canda, Abdullah Erdem and Balbay, Derya and Baydar, Dilek Ertoy and Kordan, Yakup and Esen, Tarık},
  title = {Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15553}
}
Kostenlos starten →